Article info

Download PDFPDF
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial
  1. Professor H Schmidt, Dr von Hauner Children’s Hospital, University of Munich, Lindwurmstr. 4, 80337 Munich, Germany; heinrich.schmidt{at}med.uni-muenchen.de
View Full Text

Citation

Schmidt H, Kern W, Giese R, et al
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Publication history

  • Received July 31, 2008
  • Revised September 29, 2008
  • Accepted October 2, 2008
  • First published October 23, 2008.
Online issue publication 
April 08, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.